Glycopyrrolate/indacaterol (QVA149), glycopyrrolate, indacaterol, placebo and its effect in volunteers
Phase of Trial: Phase I
Latest Information Update: 26 Feb 2014
At a glance
- Drugs Glycopyrrolate/indacaterol (Primary) ; Glycopyrrolate; Indacaterol; Salmeterol
- Indications Chronic obstructive pulmonary disease
- Focus Adverse reactions
- 26 Feb 2014 Status changed from active, no longer recruiting to completed according to results published in the International Journal of Clinical Pharmacology and Therapeutics.
- 29 May 2013 New trial record
- 22 May 2013 Results presented at the 109th International Conference of the American Thoracic Society.